SCHEMBL321042

SCHEMBL321042

CC(=O)N([Si](C)(C)C)[Si](C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.31
THPO P40225 1/20 0.31
FFAR3 O14843 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3586574 0.97 LMNA (0.31) LMNA
SCHEMBL7141286 0.91 ALDH1A1 (0.35)
SCHEMBL11259022 0.78
SCHEMBL11036001 0.71 LMNA (0.38) LMNATSHRTHPOFFAR3LCK
SCHEMBL2160280 0.71 ALDH1A1 (0.32) TSHRFFAR3LCKFYN
SCHEMBL6272854 0.69 ALDH1A1 (0.33)
SCHEMBL610853 0.69 TDP1 (0.36)
SCHEMBL273694 0.69 LMNA (0.35) LMNA
SCHEMBL537585 0.69
SCHEMBL21633440 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1024 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031747-A Mesoscopic phase enhanced polyphenol-based aggregate adhesive and preparation method thereof 华南理工大学 2026-05-15 CN claimed
CN-119822783-A High temperature resistant Al2O3-SiO2Aerogel composite material and normal pressure drying preparation method and application thereof 安徽中科恒安安全科技有限公司 2025-04-15 CN claimed
CN-119431784-A Alkali-soluble polyimide precursor, method for preparing the same, and positive photosensitive resin composition 万华化学集团股份有限公司 2025-02-14 CN claimed
CN-118908255-A Alumina-silica aerogel and preparation method and application thereof 中国科学技术大学 2024-11-08 CN claimed
CN-117925462-A Gastric acid-resistant single-bacterium-coated layer-by-layer self-assembled probiotic preparation and preparation method thereof 华南理工大学 2024-04-26 CN claimed
CN-117903421-A Salt-fog-resistant powder coating suitable for pretreatment-free substrate, polyester resin and preparation method thereof 安徽神剑新材料股份有限公司 2024-04-19 CN claimed
CN-116376368-B Micro-excitation low-carbon energy-saving coating and preparation method thereof 刘闽瑶 2024-01-26 CN claimed
CN-220176067-U A thick cauldron that evaporates for preparing bis (trimethylsilyl) acetamide 河南永源化工原料有限公司 2023-12-15 CN claimed
CN-113234716-B Method for treating immobilized enzyme by using strengthening liquid and application thereof 华南理工大学 2023-09-29 CN claimed
US-20230287032-A1 SYNTHESIS OF FLUORINATED NUCLEOTIDES MERCK SHARP & DOHME LLC (US) 2023-09-14 US claimed
EP-0277561-B1 NEW ARGININE DERIVATIVE, PROCESS FOR THE PREPARATION THEREOF AND ITS USE IN PEPTIDE SYNTHESIS ENIRICERCHE S.p.A. (IT) 1992-04-15 EP claimed
EP-0308412-B1 16$g(a)-METHYLATION PROCESS THE UPJOHN COMPANY (US) 1992-03-18 EP claimed
EP-0461407-A1 Improved process for the preparation of 2-amino(2,3,5-tri-O-benzyl-beta-D-arabinofuranosyl)adenine ASH STEVENS, INC. (US) 1991-12-18 EP claimed
US-4990612-A 16α-methylation process THE UPJOHN COMPANY (US) 1991-02-05 US claimed
EP-0336428-A2 Curable composition NIPPON PAINT CO., LTD. (JP) 1989-10-11 EP claimed
US-4831123-A ETHYLATION OF SELECTIVELY BLOCKED SISOMICIN WITH ACETALDEHYDE; REDUCTION; HYDROLYSIS SCHERING CORPORATION (US) 1989-05-16 US claimed
EP-0308412-A1 16-g(a)-METHYLATION PROCESS. UPJOHN CO (US) 1989-03-29 EP claimed
WO-1987007612-A1 16alpha-METHYLATION PROCESS THE UPJOHN COMPANY (US) 1987-12-17 WO claimed
US-4302580-A Process for the production of a cephamycin derivative MEIJI SEIKA KAISHA, LTD. (JP) 1981-11-24 US claimed
US-3956179-A STATIONARY PHASE COMPONENT FOR CATALYSIS OR CHROMATOGRAPHY Helsaz, Istvan (DT) 1976-05-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287032-A1 SYNTHESIS OF FLUORINATED NUCLEOTIDES NUDT1, NT5C3B, DUT LMNA 3581/4885TSHR 1091/4885THPO 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.